InsidersTradesSigma
Discover the complete record of transactions filed by Ahmed Nadim, 董事长兼首席执行官. Director active across 1 company, notably Cullinan Oncology, Inc.. In total, 1 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €94k. Activity tracked since 6 June 2022. The latest transaction was disclosed on 6 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Nadim Ahmed is the Chairman & CEO of Cullinan Oncology, Inc. He is responsible for the strategic direction of the company and the management of its operations. Nadim brings expertise in business development and innovation to support the company's growth.